Cardiome Pharma Corp (NASDAQ:CRME)

Data as of 3:01pm ET
 +0.31 / +3.98%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world. Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. Cardiome Pharma was founded on December 12, 1986 and is headquartered in Vancouver, Canada.

Contact Information

Cardiome Pharma Corp.
6190 Agronomy Road
Vancouver British Columbia V6T 1Z3
P:(604) 677-6905
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

William L. HunterPresident, Chief Executive Officer & Director
Sheila M. GrantChief Operating Officer
Jennifer ArchibaldChief Financial Officer
Karim F. LaljiChief Commercial Officer
Steen Juul-MöllerMedical Director-Europe

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.